510(k) DEN200044
DEN200044 is an FDA 510(k) premarket notification submitted by Perkinelmer, Inc. for the device "Eonis SCID-SMA Kit". The FDA issued a decision of De Novo granted on Nov 9, 2022. The device falls under product code QUE (Spinal Muscular Atrophy Newborn Screening Test System), a Class II device regulated under 21 CFR 866.5980. Perkinelmer, Inc. has 16 other 510(k) clearances on record.
Clearance details
- Decision
- DENG (De Novo granted)
- Decision Date
- Nov 9, 2022
- Date Received
- Jul 8, 2020
- Clearance Type
- Direct
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Spinal Muscular Atrophy Newborn Screening Test System
- Device Class
- Class II
- Regulation Number
- 866.5980
- Review Panel
- MG
- Submission Type
- 510(k)
A Spinal Muscular Atrophy (SMA) newborn screening test system is a prescription device intended to detect homozygous deletion of exon 7 or other similar mutations in the SMN1 (Survival Motor Neuron 1) gene of DNA obtained from dried blood spot specimens on filter paper using a polymerase chain reaction-based test as an aid in screening newborns for SMA. Presumptive positive results are intended to be followed up by diagnostic confirmatory testing.
Need the full FDA record for Perkinelmer, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.